ING Groep NV lowered its position in MetLife, Inc. (NYSE:MET - Free Report) by 82.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,573 shares of the financial services provider's stock after selling 21,733 shares during the period. ING Groep NV's holdings in MetLife were worth $377,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its holdings in shares of MetLife by 22.4% in the second quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider's stock valued at $378,799,000 after purchasing an additional 988,666 shares in the last quarter. Legal & General Group Plc lifted its holdings in shares of MetLife by 5.4% in the second quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider's stock valued at $371,993,000 after purchasing an additional 269,246 shares in the last quarter. Envestnet Asset Management Inc. lifted its holdings in shares of MetLife by 3.2% in the second quarter. Envestnet Asset Management Inc. now owns 3,224,930 shares of the financial services provider's stock valued at $226,358,000 after purchasing an additional 100,782 shares in the last quarter. Bessemer Group Inc. lifted its holdings in shares of MetLife by 29.7% in the first quarter. Bessemer Group Inc. now owns 2,120,275 shares of the financial services provider's stock valued at $157,133,000 after purchasing an additional 485,811 shares in the last quarter. Finally, AustralianSuper Pty Ltd lifted its holdings in shares of MetLife by 0.8% in the second quarter. AustralianSuper Pty Ltd now owns 2,063,607 shares of the financial services provider's stock valued at $144,845,000 after purchasing an additional 16,985 shares in the last quarter. Institutional investors own 89.81% of the company's stock.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on MET shares. StockNews.com upgraded MetLife from a "hold" rating to a "buy" rating in a report on Tuesday, November 12th. Piper Sandler lifted their price target on MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a report on Wednesday, October 2nd. TD Cowen initiated coverage on MetLife in a report on Wednesday, October 9th. They set a "buy" rating and a $97.00 price target on the stock. Wells Fargo & Company lifted their price target on MetLife from $92.00 to $93.00 and gave the stock an "overweight" rating in a report on Tuesday, November 5th. Finally, Bank of America decreased their target price on MetLife from $99.00 to $96.00 and set a "buy" rating for the company in a research report on Thursday, August 1st. Fourteen equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $88.46.
Get Our Latest Report on MetLife
MetLife Stock Up 0.0 %
MET stock traded up $0.04 on Monday, reaching $83.37. 1,859,542 shares of the company traded hands, compared to its average volume of 3,324,013. The firm has a fifty day simple moving average of $81.60 and a 200-day simple moving average of $75.62. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a one year low of $61.85 and a one year high of $86.94. The company has a market cap of $57.73 billion, a P/E ratio of 16.80, a price-to-earnings-growth ratio of 0.76 and a beta of 1.05.
MetLife Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be paid a dividend of $0.545 per share. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 annualized dividend and a yield of 2.61%. MetLife's dividend payout ratio is 43.95%.
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
